Insights & Perspectives

Filter by

Therapeutic Area / Research

Search Insights:
Showing 1 to 10 of 680
Filter by: Unfiltered

eBook | Aug 25, 2015

2015 Global Health and Wellness Report

Kantar Health's global health report features patient-reported outcomes data from the National Health and Wellness Survey (NHWS), the largest global self-reported general population survey in the healthcare industry. The report includes prevalence, treatment, attitudinal, lifestyle, quality-of-life and work productivity and activity impairment data from patients in 13 therapeutic areas across 10 countries.

Read more | | Share

Case Study | Aug 13, 2015

Highlighting Informal Caregivers of Patients with Schizophrenia

Sometimes those caring for patients with demanding conditions require additional help themselves. Schizophrenia is a chronic, severe and debilitating brain disorder that requires lifelong treatment.

Read more | | Share

Market Reaction | Aug 13, 2015

What is the impact on caregivers when caring for an individual with schizophrenia?

Kantar Health explores the caregiver burden of schizophrenia in the 5EU, including the activities and level of care based on the nature of schizophrenia.

Read more | | Share

Blog Post | Aug 7, 2015

Biomarker or bust? Does PD-1 therapy need a biomarker to hit the big time in NSCLC?

Opdivo (nivolumab, Bristol-Myers Squibb) is approved for the treatment of patients with squamous cell non-small cell lung cancer (NSCLC) who have relapsed on platinum-based chemotherapy. Based on the clinical trial that served as the basis for approval, Opdivo did not stratify response rates based on PD-L1 levels, and the approved label does not have a biomarker requirement.

Read more | | Share

Event Reaction | Jul 31, 2015

Key Findings from the 2015 American Society of Clinical Oncology

Kantar Health discusses the pivotal clinical trials presented at the 2015 American Society of Clinical Oncology (ASCO) annual meeting.

Read more | | Share

White Paper | Jul 27, 2015

Patient and Caregiver Insights - Analyses from the National Health and Wellness Survey (NHWS)

As the healthcare market evolves it’s more crucial than ever to be able to provide evidence of your product’s value. Kantar Health has a long-standing track record of generating evidence for our clients to maximize the value of products in all stages of the lifecycle.

Read more | | Share

Point of View | Jul 23, 2015

Snapshot: Neuropathic Pain

Neuropathic pain is a chronic condition that occurs when nerves of either the peripheral or central nervous system are damaged.

Read more | | Share

Market Reaction | Jul 23, 2015

Government Policy and Payers - Oncology Market Access U.S.

Kantar Health explores how the elimination of federal marketplace subsidies would affect affordability and adherence. We go on to discuss the current challenges with Medicare and Medicaid programs and what the future holds for these patients. Lastly, we identify how will changes in FDA regulations will affect manufacturers.

Read more | | Share

Blog Post | Jul 17, 2015

Wear it … but only if it fits

Being on the cutting edge of technology is a great thing. It’s an exciting thing. But remember that the end user experience is the most important part of developing any product or app.

Read more | | Share

Article | Jul 17, 2015

How Immunotherapies Are Changing Treatment of Non-Small Cell Lung Cancer

This year is the year of immunotherapies, as demonstrated by the focus on these at the American Society of Clinical Oncology (ASCO) annual meeting. Of particular interest is how they affect the treatment of non-small cell lung cancer (NSCLC), it being the most commonly-diagnosed cancer globally.

Read more | | Share
Page  < 12345678910 >